In a first, FTC appoints monitor in reverse-payment settlement with Endo

The following article first appeared on July 12 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com. The Federal Trade Commission appointed a monitor Tuesday to oversee a 10-year consent decree with Endo Pharmaceuticals, the first time the agency has